AI Verdict
IBO has stronger fundamentals based on our AI analysis.
IBRX vs IBO Fundamental Comparison
| Metric | IBRX | IBO |
|---|---|---|
| Revenue | $113.3M | $32,000.0 |
| Net Income | $-351.4M | $-11.8M |
| Net Margin | -310.2% | -36,993.8% |
| ROE | N/A | -93.9% |
| ROA | -70.0% | -68.0% |
| Current Ratio | 5.10x | 0.35x |
| Debt/Equity | N/A | 0.00x |
| EPS | $-0.38 | $-0.38 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IBRX vs IBO: Frequently Asked Questions
Is IBRX or IBO a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), IBO has stronger fundamentals. IBRX is rated STRONG SELL (92% confidence) while IBO is rated STRONG SELL (95% confidence). This is not investment advice.
How does IBRX compare to IBO fundamentally?
ImmunityBio, Inc. has ROE of N/A vs IMPACT BIOMEDICAL INC.'s -93.9%. Net margins are -310.2% vs -36,993.8% respectively.
Which stock pays higher dividends, IBRX or IBO?
IBRX has a dividend yield of N/A or no dividend while IBO has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IBRX or IBO for long term?
For long-term investing, consider that IBRX has STRONG SELL rating with 92% confidence, while IBO has STRONG SELL rating with 95% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IBRX vs IBO?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IBRX vs IBO, the AI consensus favors IBO based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.